Test 400

Test 400 is a high-concentration testosterone preparation delivering 400 milligrams of hormone per milliliter of carrier oil. This formulation typically combines multiple testosterone esters — commonly a blend of decanoate, enanthate, and cypionate — to achieve the elevated concentration while maintaining solution stability. The high mg/ml rating is an engineering achievement: standard testosterone preparations top out at 200-300mg/ml before solubility and viscosity constraints emerge, requiring additional solvents (typically benzyl benzoate and benzyl alcohol at higher ratios) to keep the compound in solution.

The pharmacological action is pure testosterone. Once injected and the esters are cleaved, the body processes it identically to any other testosterone preparation — androgen receptor activation, enhanced nitrogen retention, elevated protein synthesis, increased erythropoiesis, and the full spectrum of androgenic and anabolic effects. The multi-ester composition creates a staggered release profile: shorter esters provide an initial serum spike within 24-48 hours, while longer esters sustain elevated levels over 10-14 days.

The primary advantage of Test 400 is volumetric efficiency. Researchers running supraphysiological testosterone doses (500mg/week and above) can achieve their target with significantly less injection volume. At 400mg/ml, a 500mg weekly dose requires just 1.25ml — compared to 2.5ml of a standard 200mg/ml preparation. This matters for researchers managing injection site rotation, minimizing tissue disruption, or stacking multiple injectables where total weekly oil volume becomes a practical concern.

Test 400 is formulated for experienced researchers who have established their testosterone tolerance and are running doses that make high-concentration preparations practical. The elevated solvent ratios necessary to maintain 400mg/ml in solution can produce more post-injection discomfort (PIP) than lower-concentration preparations, particularly in virgin muscle groups. This is not a beginner compound — researchers new to injectable protocols should establish their baseline response with standard 200-250mg/ml testosterone before graduating to high-concentration formulations.

Administration frequency follows the ester blend — typically once or twice weekly. Researchers should be aware that the higher solvent content may require slower injection speed and warming the oil to body temperature before administration to reduce viscosity and post-injection soreness. Estrogen management, ancillary support, and PCT protocols are identical to those used with any testosterone preparation at the equivalent weekly milligram dose. Pair with an aromatase inhibitor based on bloodwork, and plan PCT timing around the longest ester in the blend (typically decanoate, with a 7-10 day half-life).